Status:
TERMINATED
TEG 6s® for Perioperative Monitoring of Platelet Function During Cardiopulmonary Bypass for Cardiac Surgery
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Cardiopulmonary Bypass
Eligibility:
All Genders
18+ years
Brief Summary
Excessive bleeding is common during cardiopulmonary bypass (CPB) for cardiac surgery. This may result from the systemic activation of the coagulation pathway and the acquired platelet dysfunction duri...
Detailed Description
Excessive bleeding is common during cardiopulmonary bypass (CPB) for cardiac surgery. This may result from the systemic activation of the coagulation pathway and the acquired platelet dysfunction duri...
Eligibility Criteria
Inclusion
- Patients scheduled to undergo cardiopulmonary bypass
- Informed consent
Exclusion
- Age \<18 years
- Pregnant women
- Emergency surgery
- Cardiac surgery without CPB
- thrombocytopenia \<100000/mmm3
Key Trial Info
Start Date :
April 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 7 2021
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04746560
Start Date
April 21 2021
End Date
May 7 2021
Last Update
January 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Département d'Anesthésie-Réanimation,Hopital Pitié Salpêtrière
Paris, France, 75013